1. Home
  2. PACK vs CRVS Comparison

PACK vs CRVS Comparison

Compare PACK & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACK
  • CRVS
  • Stock Information
  • Founded
  • PACK 1972
  • CRVS 2014
  • Country
  • PACK United States
  • CRVS United States
  • Employees
  • PACK N/A
  • CRVS N/A
  • Industry
  • PACK Containers/Packaging
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PACK Consumer Discretionary
  • CRVS Health Care
  • Exchange
  • PACK Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • PACK 313.3M
  • CRVS 305.4M
  • IPO Year
  • PACK N/A
  • CRVS 2016
  • Fundamental
  • Price
  • PACK $5.29
  • CRVS $5.75
  • Analyst Decision
  • PACK Buy
  • CRVS Strong Buy
  • Analyst Count
  • PACK 3
  • CRVS 4
  • Target Price
  • PACK $7.17
  • CRVS $15.00
  • AVG Volume (30 Days)
  • PACK 1.3M
  • CRVS 518.7K
  • Earning Date
  • PACK 10-30-2025
  • CRVS 08-07-2025
  • Dividend Yield
  • PACK N/A
  • CRVS N/A
  • EPS Growth
  • PACK N/A
  • CRVS N/A
  • EPS
  • PACK N/A
  • CRVS N/A
  • Revenue
  • PACK $380,700,000.00
  • CRVS N/A
  • Revenue This Year
  • PACK $10.14
  • CRVS N/A
  • Revenue Next Year
  • PACK $7.92
  • CRVS N/A
  • P/E Ratio
  • PACK N/A
  • CRVS N/A
  • Revenue Growth
  • PACK 10.38
  • CRVS N/A
  • 52 Week Low
  • PACK $2.91
  • CRVS $2.54
  • 52 Week High
  • PACK $8.70
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • PACK 67.12
  • CRVS 65.10
  • Support Level
  • PACK $5.02
  • CRVS $5.28
  • Resistance Level
  • PACK $6.31
  • CRVS $5.64
  • Average True Range (ATR)
  • PACK 0.33
  • CRVS 0.30
  • MACD
  • PACK 0.10
  • CRVS 0.03
  • Stochastic Oscillator
  • PACK 55.24
  • CRVS 77.70

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: